- Home
- NAVI vs AUPH Comparison
NAVI vs AUPH Comparison
Compare NAVI & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAVI
- AUPH
- Stock Information
- Founded
- NAVI 1973
- AUPH 1993
- Country
- NAVI United States
- AUPH Canada
- Employees
- NAVI N/A
- AUPH N/A
- Industry
- NAVI Investment Bankers/Brokers/Service
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- NAVI Finance
- AUPH Health Care
- Exchange
- NAVI Nasdaq
- AUPH Nasdaq
- Market Cap
- NAVI N/A
- AUPH 1.1B
- IPO Year
- NAVI N/A
- AUPH 1999
- Fundamental
- Price
- NAVI $12.98
- AUPH $8.19
- Analyst Decision
- NAVI Hold
- AUPH Strong Buy
- Analyst Count
- NAVI 7
- AUPH 2
- Target Price
- NAVI $13.79
- AUPH $11.50
- AVG Volume (30 Days)
- NAVI 742.9K
- AUPH 1.3M
- Earning Date
- NAVI 04-23-2025
- AUPH 05-01-2025
- Dividend Yield
- NAVI 4.94%
- AUPH N/A
- EPS Growth
- NAVI N/A
- AUPH N/A
- EPS
- NAVI 1.18
- AUPH 0.04
- Revenue
- NAVI $848,000,000.00
- AUPH $235,133,000.00
- Revenue This Year
- NAVI N/A
- AUPH $11.86
- Revenue Next Year
- NAVI $0.88
- AUPH $24.96
- P/E Ratio
- NAVI $10.97
- AUPH $204.13
- Revenue Growth
- NAVI N/A
- AUPH 33.97
- 52 Week Low
- NAVI $12.35
- AUPH $4.71
- 52 Week High
- NAVI $17.56
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- NAVI 43.35
- AUPH 48.74
- Support Level
- NAVI $12.35
- AUPH $7.93
- Resistance Level
- NAVI $13.41
- AUPH $8.73
- Average True Range (ATR)
- NAVI 0.36
- AUPH 0.23
- MACD
- NAVI -0.05
- AUPH -0.04
- Stochastic Oscillator
- NAVI 44.68
- AUPH 32.50
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.